About eval.bio
Founded in 2025 in Helsinki, Eval.bio is a boutique life science analytics and communications firm. Our vision is to become a Nordic partner of choice in life science analysis and communication — with clarity at the core.
Business is hard enough — market analyses and valuations should bring clarity to strategy, not complicate it. We believe effective stakeholder engagement requires analysis that is both aligned with reality and well-articulated.
Our approach
We help you convey the value proposition to stakeholders — influencing decisions in your favor.
Identify and validate what drives opportunity value and the strategic outcomes you need.
Distill evidence into decisions — not decks for their own sake.
Align messages with reality so stakeholders buy in when it matters.
Connect analysis to capital, partnerships, and portfolio moves.
Team
Lead analyst
Sebastian is an experienced analyst and life science communicator with core expertise in biotech business development and market analysis. He has evaluated market opportunities, conducted asset valuations, and facilitated deals across therapy areas and modalities. His corporate slide decks have attracted multimillion financing; he is known for clear business and science presentations.
MBA in Biobusiness · MSc Drug Discovery
Questions? Get in touch